OA08506A - Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function. - Google Patents
Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function.Info
- Publication number
- OA08506A OA08506A OA59095A OA59095A OA08506A OA 08506 A OA08506 A OA 08506A OA 59095 A OA59095 A OA 59095A OA 59095 A OA59095 A OA 59095A OA 08506 A OA08506 A OA 08506A
- Authority
- OA
- OAPI
- Prior art keywords
- compounds
- prophylaxis
- treatment
- disorders
- agents containing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000001777 nootropic effect Effects 0.000 title abstract 3
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 230000003920 cognitive function Effects 0.000 title 1
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Epoxy Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention relates to novel compounds having a nootropic activity, the use of ACE inhibitors as medicaments having nootropic activity, agents containing them, and their use in the treatment and prophylaxis of cognitive malfunctions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863610391 DE3610391A1 (en) | 1986-03-27 | 1986-03-27 | COMPOUNDS WITH NOOTROPPER ACTION, THESE CONTAINERS AND THEIR USE IN THE TREATMENT AND PROPHYLAXIS OF COGNITIVE DYSFUNCTIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA08506A true OA08506A (en) | 1988-07-29 |
Family
ID=6297417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59095A OA08506A (en) | 1986-03-27 | 1987-03-27 | Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0243645B1 (en) |
| JP (1) | JPS62240698A (en) |
| KR (1) | KR870008841A (en) |
| CN (1) | CN1031267C (en) |
| AT (1) | ATE102954T1 (en) |
| AU (1) | AU621278B2 (en) |
| CA (1) | CA1341064C (en) |
| CS (2) | CS651989A3 (en) |
| DD (1) | DD280765A5 (en) |
| DE (2) | DE3610391A1 (en) |
| DK (1) | DK172221B1 (en) |
| EG (1) | EG18175A (en) |
| ES (1) | ES2061447T3 (en) |
| FI (1) | FI91876C (en) |
| HU (2) | HU203117B (en) |
| IE (1) | IE62456B1 (en) |
| MA (1) | MA20919A1 (en) |
| NO (1) | NO178546C (en) |
| NZ (1) | NZ219764A (en) |
| OA (1) | OA08506A (en) |
| PH (1) | PH27210A (en) |
| PT (1) | PT84564B (en) |
| RU (1) | RU1836335C (en) |
| TN (1) | TNSN87045A1 (en) |
| ZA (1) | ZA872230B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| CA1321753C (en) * | 1987-04-27 | 1993-08-31 | Abraham Sudilovsky | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
| DE3731085A1 (en) * | 1987-09-16 | 1989-04-06 | Hoechst Ag | NEW AMINO ACID ESTERS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF |
| DE3739690A1 (en) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS |
| DE3801587A1 (en) * | 1988-01-21 | 1989-08-03 | Hoechst Ag | NEW AMINO ACID GLYCERIDES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF |
| EP0331609A3 (en) * | 1988-01-27 | 1992-07-01 | Hoechst Aktiengesellschaft | Angiotensin converting enzyme inhibitors having psychotropic effects |
| DE3803225A1 (en) * | 1988-02-04 | 1989-08-17 | Hoechst Ag | AMINO ACID AMIDE WITH PSYCHOTROPIC EFFECT, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING THE SAME AND THEIR USE |
| JPH01275529A (en) * | 1988-03-21 | 1989-11-06 | E R Squibb & Sons Inc | Suppressing treatment agent of delayed motion effect |
| US5037821A (en) * | 1988-06-01 | 1991-08-06 | E. R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor |
| US5093129A (en) * | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
| US5032578A (en) * | 1990-09-17 | 1991-07-16 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| EP1372620A2 (en) * | 2001-03-15 | 2004-01-02 | Saegis Pharmaceuticals | Methods for restoring cognitive function following systemic stress |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE20469T1 (en) * | 1980-10-23 | 1986-07-15 | Schering Corp | CARBOXYALKYL DIPEPTIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM. |
| DE3300774A1 (en) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | NEW SPIROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AND NEW SPIROCYCLIC AMINO ACIDS AS INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF |
-
1986
- 1986-03-27 DE DE19863610391 patent/DE3610391A1/en not_active Withdrawn
-
1987
- 1987-03-18 ES ES87103938T patent/ES2061447T3/en not_active Expired - Lifetime
- 1987-03-18 DE DE87103938T patent/DE3789330D1/en not_active Expired - Lifetime
- 1987-03-18 AT AT87103938T patent/ATE102954T1/en not_active IP Right Cessation
- 1987-03-18 EP EP87103938A patent/EP0243645B1/en not_active Expired - Lifetime
- 1987-03-25 DD DD87301118A patent/DD280765A5/en not_active IP Right Cessation
- 1987-03-25 PH PH35073A patent/PH27210A/en unknown
- 1987-03-25 HU HU871308A patent/HU203117B/en unknown
- 1987-03-25 MA MA21159A patent/MA20919A1/en unknown
- 1987-03-25 EG EG18087A patent/EG18175A/en active
- 1987-03-25 FI FI871304A patent/FI91876C/en not_active IP Right Cessation
- 1987-03-25 NZ NZ219764A patent/NZ219764A/en unknown
- 1987-03-25 HU HU896609A patent/HU202118B/en unknown
- 1987-03-26 NO NO871282A patent/NO178546C/en unknown
- 1987-03-26 CA CA000533092A patent/CA1341064C/en not_active Expired - Lifetime
- 1987-03-26 JP JP62070541A patent/JPS62240698A/en active Pending
- 1987-03-26 DK DK153587A patent/DK172221B1/en not_active IP Right Cessation
- 1987-03-26 RU SU874202302A patent/RU1836335C/en active
- 1987-03-26 KR KR870002775A patent/KR870008841A/en not_active Ceased
- 1987-03-26 IE IE78487A patent/IE62456B1/en not_active IP Right Cessation
- 1987-03-26 PT PT84564A patent/PT84564B/en unknown
- 1987-03-26 ZA ZA872230A patent/ZA872230B/en unknown
- 1987-03-26 AU AU70649/87A patent/AU621278B2/en not_active Expired
- 1987-03-27 CS CS896519A patent/CS651989A3/en not_active IP Right Cessation
- 1987-03-27 CS CS872126A patent/CS276179B6/en unknown
- 1987-03-27 TN TNTNSN87045A patent/TNSN87045A1/en unknown
- 1987-03-27 OA OA59095A patent/OA08506A/en unknown
- 1987-03-27 CN CN87102304A patent/CN1031267C/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA08506A (en) | Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function. | |
| IL89031A0 (en) | Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation | |
| FR2430408A1 (en) | OPTICALLY ACTIVE PHENETHANOLAMINES AND THEIR THERAPEUTIC USE | |
| EP0261595A3 (en) | Pharmaceutical composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-didehydrocytidine) for treating patients infected with retrovirus | |
| FR2398067A1 (en) | NEW 4-PYRONES SUBSTITUTED IN POSITIONS 2, 3 AND 6 AND MEDICINAL PRODUCTS CONTAINING THEM | |
| DE69330150D1 (en) | Pharmaceutical compositions for transdermal administration of melatonin and / or its analogs | |
| ES8604597A1 (en) | Thiopyranopyrimidine compounds and acid addition salts thereof | |
| DE69327207D1 (en) | Tryptamine to treat circadian rhythm disorders | |
| DK671087D0 (en) | USE OF 5-ARYL-3H-1,2,4-TRIAZOL-3-ONES AS ANTICONVULSIVE | |
| UA19674A (en) | Composition for treating contact lenses | |
| EP0667157A4 (en) | SYMPTOMATIC TREATMENT OF CIRCULATORY DISORDERS. | |
| FR2575158B1 (en) | ARYLALCOYLOXYMETHYL-2 MORPHOLINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| IT8719882A0 (en) | SULPHYDRyl COMPOUNDS TO SUPPRESS THE INHIBITORY EFFECTS OF NAD DEGRADATION PRODUCTS ON LD-L ACTIVITY. | |
| ATE72115T1 (en) | APPLICATION OF 1,6-DIMETHYL-4-OXO-1,6,7,8,9A- | |
| FR2584821B3 (en) | PROCESS FOR THE TREATMENT OF OILS CONTAINING CHLORINATED BIPHENYLES | |
| DE69109933D1 (en) | Use of mizoribin to treat or prevent multiple sclerosis. | |
| DE68910820D1 (en) | Treatment of petroleum coke to prevent bloating. | |
| ATE94758T1 (en) | USE OF GANGLIOSIDES TO TREAT AUTONOMOUS NERVOUS SYSTEM DYSFUNCTION IN CHAGAS DISEASE. | |
| EP0228034A3 (en) | Arginine and agmatine derivatives for treating protozoal infections | |
| IT8722734A0 (en) | EQUIPMENT FOR THE REGENERATION AND PURIFICATION OF BLOOD. | |
| ZA89574B (en) | Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system |